Introduction: Prediction of neurodevelopmental outcome in infants with hypoxic-ischemic
encephalopathy remains an important challenge. Various studies have shown that the …

Therapeutic hypothermia (TH) is a recommended regimen for newborn infants who are at or
near term with evolving moderate-to-severe hypoxic ischemic encephalopathy (HIE). The …

Background In neonatal encephalopathy, the clinical manifestations of injury can only be
reliably assessed several years after an intervention, complicating early prognostication and …

Abstract Background Despite therapeutic hypothermia 30-70% of newborns with moderate
or severe hypoxic ischemic encephalopathy will die or survive with significant long-term …

Aim To determine whether corpus callosum (CC) and corticospinal tract (CST) diffusion
tensor imaging (DTI) measures relate to developmental outcome in encephalopathic …

Objective To determine the optimal quantitative magnetic resonance (MR) biomarker in
neonatal encephalopathy following therapeutic hypothermia based on scan timing. Study …

The specific cytopathology that causes abnormal fractional anisotropy (FA) and mean
diffusivity (MD) from diffusion tensor imaging (DTI) after neonatal hypoxia‐ischemia (HI) is …

Objective To evaluate whether structural and microstructural brain abnormalities in neonates
with congenital heart disease (CHD) correlate with neuronal network dysfunction measured …

Background Identification of early signs of hypoxic ischemic encephalopathy (HIE) with
magnetic resonance imaging (MRI) has proven of prognostic significance. Yet, the …

Despite therapeutic hypothermia, survivors of neonatal encephalopathy have high rates of
adverse outcome. Early surrogate outcome measures are needed to speed up the …